Novilytic
PrivateLast Round
Early Funding
Dec 15, 2025
Total Funding Raised
$4.49M
Momentum Score
50 /100
Company Overview
Novilytic is a biotechnology and nanotechnology company that has developed a platform to monitor the quality of lifesaving medicines in biopharmaceutical manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Quality Management, Biotech Equipment, Biotechnology, Advanced Materials, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novilytic Comps
Public and private peers based on sector, stage, and business model.
Novilytic Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Dec 15, 2025 | ||||
| Accelerator | Nov 19, 2025 | ||||
| Seed | May 3, 2022 | ||||
| Early Funding | Apr 13, 2021 | ||||
| Grant | Jul 16, 2020 |
Key People
Founding team and executive leadership
Novilytic Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elevate Ventures | Seed |
| NIH RADx | Grant |
| Purdue Foundry | Seed |
| National Institute of General Medical Sciences | Grant |
| BioTools Innovator VANGUARD | Accelerator |
Novilytic Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Novilytic's valuation, stock price, and market status.
